Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment-Reference-Cited by-同舟云学术

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

Published:2022-01-27 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Bendtsen Simone Kloch¹^ORCID,Perez-Penco Maria¹^ORCID,Hübbe Mie Linder¹^ORCID,Martinenaite Evelina¹^ORCID,Orebo Holmström Morten¹^ORCID,Weis-Banke Stine Emilie¹^ORCID,Grønne Dahlager Jørgensen Nicolai¹^ORCID,Jørgensen Mia Aaboe¹^ORCID,Munir Ahmad Shamaila¹^ORCID,Jensen Kasper Mølgaard¹^ORCID,Friese Christina¹^ORCID,Lundsager Mia Thorup¹^ORCID,Johansen Astrid Zedlitz¹^ORCID,Carretta Marco¹^ORCID,Ødum Niels²^ORCID,Met Özcan¹²^ORCID,Svane Inge Marie¹^ORCID,Madsen Daniel Hargbøl¹²^ORCID,Andersen Mads Hald¹²^ORCID

Affiliation:

1. National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark

2. Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

Funder

Danish Health Authority grant “Empowering Cancer Immunotherapy in Denmark

Copenhagen University Hospital Herlev and Gentofte

Danish Council for Independent Research

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link